Tailored HLA reagents HLA Protein Technologies offers the largest selection of soluble, natively folded HLA proteins across Class I and II, with off-the-shelf options and custom validation services. Sales opportunity: position the company as a one-stop shop for researchers needing standardized, high-fidelity HLA reagents and custom epitope mapping to accelerate immune characterization projects.

Natively folded advantage Emphasize the higher binding fidelity and reduced nonspecific interactions that come with natively folded proteins. Sales angle: highlight improved assay accuracy for T-cell and B-cell research, which can translate into more reliable antibody detection, epitope mapping, and reproducible experiment results for customers.

Recent portfolio expansion Recent launch of soluble HLA-G product line signals active product development and capacity to address broader immunology research needs. Sales approach: target labs focusing on immune tolerance, transplantation, and regulatory pathways who can benefit from the expanded sHLA portfolio.

Flexible engagement Offer a mix of off-the-shelf proteins plus custom validation and T-Cell epitope mapping services, enabling tailored solutions for research pipelines. Sales tactic: propose bundled offerings and pilot projects to de-risk adoption and demonstrate value quickly.

Growth-minded fit With revenue in the low-to-mid single digits and a scalable platform supported by AWS, WordPress, and e-commerce capabilities, HLA Protein is positioned to scale with growing R&D demand. Sales play: identify mid-market institutions and CROs seeking scalable, reliable HLA reagent supply to support expanding projects in immunology and vaccine research.